Health Check: Polynovo shares go crackers after positive US reimbursement changes
4 Articles
4 Articles
Guess which ASX 200 stock is rocketing on big US news
Polynovo Ltd (ASX: PNV) shares have returned from a trading halt with a bang. At one stage today, the ASX 200 stock was up as much as 26% to $1.66. The medical device company's shares have faded since then but remain up almost 9% to $1.43 in late afternoon trade. Why is this ASX 200 stock rocketing? Investors have been scrambling to buy Polynovo's shares following the release of an update on the impacts of proposed changes to U.S. Medicare Reimb…
Long-term Polynovo shareholders see relief as US Medicare changes offer boon
Healthcare player Polynovo (ASX:PNV) has offered relief to long-term shareholders who may have been bemoaning 1Y returns down -30%. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more. Thanks to changes in the U.S. medicare system around how skin healing products are reimbursed, ultimately offering the potential for higher penetration of the comp…
Health Check: Polynovo shares go crackers after positive US reimbursement changes
Perversely, Polynovo stands to benefit from a US reimbursement cut for outpatients ASX biotechs had a poor August, but they will Spring into action Race Oncology opens Hong Kong site in “cautious” trial rollout PolyNovo (ASX:PNV) shares have sprung to a perky Spring start, soaring up to 25% on news of a favourable US reimbursement change for outpatient wound care procedures. Glad to hear that someone’s happy with the RFK Junior regime! As Poly…
PolyNovo Poised to Benefit from Proposed U.S. Medicare Reimbursement Changes
PolyNovo Limited (ASX:PNV), a disruptive ASX 200 medical technology company based in Melbourne, specialises in products that simplify the management of acute complex wounds. The company has released an announcement outlining the potential impact and opportunity presented by proposed changes to U.S. Medicare reimbursement for outpatient wound care. The changes, detailed in a recent article in The Australian, address current disincentives in the s…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium